however, further research is needed to understand the relationship between dose, duration of administration, and the frequency and duration of migraine attacks (8285)
They found that the two are related, but that doesnt mean we understand why, says Vicente Diaz, MD, Yale Medicine ophthalmologist and assistant professor of ophthalmology and visual science at Yale School of Medicine
Preclinical findings should remain model-specific
However, because it does not block androgen or progesterone receptors like spironolactone, hormone-related adverse effects such as gynecomastia and menstrual irregularities are expected to occur less frequently
When demand exceeds evidence, an unregulated marketplace frequently fills the gap